Nyla Whitehead, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 11011 Sheridan St Ste 211, Cooper City, FL 33026 Phone: 954-667-7261 |
Mrs. Staci Lee Schnell, M.S., C.S., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 12323 Sw 55th St, Suite 1003, Cooper City, FL 33330 Phone: 954-680-1211 |
Mr. David S Caswell Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 12323 Sw 55th St, Cooper City, FL 33330 Phone: 954-680-1210 |
Irene J Marshall, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 12323 Sw 55th St, Suite 1003, Cooper City, FL 33330 Phone: 954-680-1211 |
Mrs. Alisa Feiner, LCSW LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2525 Embassy Drive South, Suite 3, Cooper City, FL 33026 Phone: 954-436-3800 Fax: 954-436-3700 |
News Archive
Technology in common household humidifiers could enable the next wave of high-tech medical imaging and targeted medicine, thanks to a new method for making tiny silicone microspheres developed by chemists at the University of Illinois.
Research can now target metastases more effectively thanks to a new approach that takes into account the enormous heterogeneity and phenotypes of tumor cells, with a team from UNIGE pinpointing a gene that prevents their development.
University of Illinois at Chicago researcher Dr. John Quigley will describe a promising new approach to blocking malaria transmission during the American Society of Hematology's annual meeting in Orlando, Fla.
Detection of malignant skin alterations is currently aided by optical microscopes such as dermoscopes or optical microscopes. While the latter offers high resolution, it comes with a major disadvantage, just like any other purely microscopic method: it only provides a partial view of the skin due to the low penetration depth.
In a large study of pediatric cancer patients, researchers from Children's Hospital of Philadelphia have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors.
› Verified 9 days ago